Company Profiles

driven by the PitchBook Platform

Axerion Therapeutics

Description

Developer of therapeutics. The company develops therapeutics for neurological diseases and injuries.

2010

Founded

PRIVATE

Status

1-10

Employees

Conv. Debt

Latest Deal Type

$500k

Latest Deal Amount

$1.66M

Total Amount Raised

Description

Developer of therapeutics. The company develops therapeutics for neurological diseases and injuries.

Website:

www.axeriontherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Discovery Tools (Healthcare)
Therapeutic Devices

Primary Office

688 East Main Street Suite 1 Branford, CT 06405United States +1 (203) 208-2384
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Axerion Therapeutics's full profile, request a free trial.

Axerion Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Axerion Therapeutics Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
State of ConnecticutGovernment000 0000000 0000
Connecticut Innovations Venture Capital
State of Connecticut Government

Axerion Therapeutics Executive Team (6)

NameTitleBoard
Seat
Contact
Info
George MaynardChief Scientific Officer
Dana Wirak Ph.DDirector
Sylvia McBrinnCo-Founder & Board Member
Stephen StrittmatterCo-Founder
Eric FriedenVice President, Process Science and Manufacturing
George Maynard Chief Scientific Officer
Dana Wirak Ph.D Director
Sylvia McBrinn Co-Founder & Board Member
Stephen Strittmatter Co-Founder
Eric Frieden Vice President, Process Science and Manufacturing

Axerion Therapeutics Board Members (5)

NameRepresentingRoleSinceContact
Info
David ScheerSelfChairman000 0000
John PuzissSelfBoard Member000 0000
Lillian MuConnecticut InnovationsSenior Investment Associate000 0000
Russell TweeddaleConnecticut InnovationsManaging Director, Investments000 0000
Sylvia McBrinnAxerion TherapeuticsCo-Founder & Board Member000 0000
David Scheer Chairman Self
John Puziss Board Member Self
Lillian Mu Senior Investment Associate Connecticut Innovations
Russell Tweeddale Managing Director, Investments Connecticut Innovations
Sylvia McBrinn Co-Founder & Board Member Axerion Therapeutics
Request full access to PitchBook